[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100656789":3},{"organization":4,"outcomesModule":7,"designInfo":29,"detailedDescription":28,"studyPopulation":28,"armGroups":35,"interventions":41,"overallOfficials":45,"centralContacts":49,"locations":55,"responsibleParty":72,"collaborators":28,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":82,"sex":83,"minAge":84,"maxAge":85,"enrollmentInfo":86,"targetDuration":28,"studyType":89,"phases":90,"briefSummary":91,"conditions":92,"keywords":94,"overallStatus":99,"whyStopped":28,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"University Hospital, Clermont-Ferrand","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":28},[9],{"measure":10,"description":11,"timeFrame":12},"transcriptomic markers in children under 4 years of age that predict a predisposition to being overweight at age 6 (BMI > IOTF25).","Ranking of the discriminative capacity of adipocyte and blood transcripts before 4 years of age to predict the development of overweight (BMI \\> IOTF25) at age 6, using Partial Least Squares Discriminant Analysis (PLS-DA).","perioperative",[14,18,22,25],{"measure":15,"description":16,"timeFrame":17},"analyze weight trajectories","Selection and validation of transcriptomic markers for the development of a predictive score for the risk of overweight and obesity in children","at age 6 years",{"measure":19,"description":20,"timeFrame":21},"molecular and epigenetic mechanisms associated with the identified transcriptomic signatures.","methylation profiles","at the time of blood ans adipose tissu sampling",{"measure":23,"description":24,"timeFrame":12},"comparison of transcriptomic expression levels between blood and adipose tissue","percentage of common markers sampled from blood and adipose tissue",{"measure":26,"description":27,"timeFrame":17},"develop a quantitative test based on digital PCR to define individual expression thresholds predictive of risk","Performance of the digital PCR test evaluated by the ability to discriminate weight trajectories (AUC of ROC curves).",null,{"allocation":30,"interventionModel":31,"interventionModelDescription":28,"primaryPurpose":32,"observationalModel":28,"timePerspective":28,"maskingInfo":33},"NA","SINGLE_GROUP","SCREENING",{"masking":34,"maskingDescription":28,"whoMasked":28},"NONE",[36],{"label":37,"type":38,"description":28,"interventionNames":39},"early transcriptomic markers","EXPERIMENTAL",[40],"Other: early transcriptomic markers",[42],{"type":6,"name":37,"description":43,"armGroupLabels":44,"otherNames":28},"during a scheduled surgery before the age of 4 years, collection of a blood sample (2.5 mL in a PAXgene tube) and two adipose tissue fragments, each measuring 5 mm x 5 mm x 5 mm.\n\ntracking of weight and height curves from birth to age 6",[37],[46],{"name":47,"affiliation":5,"role":48},"Etienne Merlin","PRINCIPAL_INVESTIGATOR",[50],{"name":51,"role":52,"phone":53,"phoneExt":28,"email":54},"Lise Laclautre","CONTACT","+334754963","promo_interne_drci@chu-clermontferrand.fr",[56],{"facility":57,"status":28,"city":58,"state":28,"zip":59,"country":60,"countryCode":61,"cosmosGeoPoint":62,"geoPoint":67,"contacts":68},"CHU de Clermont-Ferrand","Clermont-Ferrand","63000","France","FR",{"type":63,"coordinates":64},"Point",[65,66],3.08682,45.77969,{"lat":66,"lon":65},[69,71],{"name":51,"role":52,"phone":70,"phoneExt":28,"email":54},"+33473754963",{"name":47,"role":48,"phone":28,"phoneExt":28,"email":28},{"type":73,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR","100656789","childhood-obesity-risk-markers-mariobe-100656789",false,"NCT07831291","Childhood Obesity Risk Markers (MARIOBE)","Childhood Obesity Risk Markers","MARIOBE","Inclusion Criteria:\n\n* Child scheduled for surgery allowing for the harvesting of adipose tissue.\n\nExclusion Criteria:\n\n* Child whose holders of parental authority are protected by law",true,"ALL","1 Day","4 Years",{"count":87,"type":88},400,"ESTIMATED","INTERVENTIONAL",[30],"Metabolic diseases, including childhood obesity, represent a major public health challenge. Studies in mice have identified transcriptomic markers in adipose tissue capable of predicting a predisposition to obesity prior to any weight gain. The MARIOBE project aims to translate this approach to young children (≤ 4 years old) in order to identify individual vulnerability to obesity at an early stage.",[93],"Obesity & Overweight",[95,96,97,98],"obesity","transcriptomic","overweight","children","NOT_YET_RECRUITING","2026-09-15",{"date":102,"type":103},"2026-09-21","ACTUAL",{"date":105,"type":88},"2026-09",{"date":107,"type":88},"2036-09",{"name":5,"class":6},1]